Additionally, given the specificity of the A + B hairpin for IKKα over IKKβ and NEMO, targeting this hairpin could provide a more precise therapeutic approach with fewer off-target effects, particularly in cancers where IKKα-driven NF-κB signaling is a driving factor. The gene discussed is NFKB1; the disease is cancer.